Fresenius Medical (FMS) Care announced the launch of the first tranche of its initial EUR 1B share buyback, which is part of its new capital allocation framework as presented at its Capital Markets Day on June 17. The first tranche of up to EUR 600M was initiated, which is planned to be completed at the latest by April 30, 2026.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMS:
- Fresenius Medical price target lowered to EUR 48 from EUR 50 at Deutsche Bank
- Hold Rating Maintained for Fresenius Medical Care Amidst Flat US Growth and Downward Financial Adjustments
- Fresenius Medical Care Reports Modest Growth in 2025 Earnings
- Fresenius Medical Care’s Earnings Call Highlights Growth Amid Challenges
- Fresenius Medical Care Restructures with New Value-Based Care Segment